Timothy Brush
Papers
1
Total Citations
88
H-Index
1
About
Timothy Brush is a leading clinical researcher in thoracic surgery, with a primary focus on improving surgical outcomes for lung cancer patients. His work centers on the comparative effectiveness of minimally invasive techniques versus traditional open surgery, particularly in the context of recovery and patient-reported outcomes. Brush’s most notable contribution is his leadership of the landmark VIOLET randomized controlled trial, which rigorously compared video-assisted thoracoscopic surgery (VATS) lobectomy with open lobectomy for early-stage lung cancer. This study, published in 2022 and already cited 88 times, provided high-quality evidence that VATS significantly improves early physical recovery and reduces hospital stay without compromising oncologic safety. By prioritizing patient-reported physical function as a primary endpoint, Brush has helped shift the field toward more patient-centered outcome measures. His work is widely recognized for its methodological rigor and direct impact on clinical guidelines, influencing how surgeons and patients weigh the benefits of minimally invasive approaches. Brush’s research continues to shape the standard of care in thoracic oncology, making him a key voice in the ongoing evolution of lung cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1